GlassScriptPhysician profile
Nancy A Hurchik Munaco
NPI 1629047444
$1,480.16
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,175 · 2020: $287 · 2021: $17.87.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $288.31 | 2019-2020 | |
| Pfizer INC. | $253.24 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $188.69 | 2019-2020 | |
| Glaxosmithkline, LLC. | $126.24 | 2019-2020 | |
| Astellas Pharma US INC | $118.23 | 2019-2020 | |
| Novo Nordisk INC | $90.64 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.24 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $59.33 | 2019 | |
| Shire North American Group INC | $41.31 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $39.68 | 2019-2020 | |
| Amarin Pharma, INC. | $30.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $29.54 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $25.84 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $24.94 | 2019-2020 | |
| Allergan, INC. | $22.81 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18.09 | 2019 | |
| Eisai INC. | $14.72 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.98 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.48 | 2019 | |
| Lilly USA, LLC | $11.63 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Hurchik Munaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.